Efficacy and safety of etanercept biosimilar rhTNFR-Fc in Chinese patients with juvenile idiopathic arthritis: An open-label multicenter observational study

BACKGROUND: Etanercept biosimilar recombinant human TNF-α receptor II: IgG Fc fusion protein (rhTNFR-Fc) has showed its efficacy and safety in Chinese patients with rheumatoid arthritis. However, data on rhTNFR-Fc's application in juvenile idiopathic arthritis (JIA) is limited. METHODS: A prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xuefeng, Liu, Xiaohui, Zheng, Wenjie, Xiao, Jihong, Li, Xiaozhong, Wu, Ling, Zou, Lixia, Ouyang, Qian, Shangguan, Yaoyao, Lin, Kezhao, Dai, Xiaomei, Chen, Yuanling, Xu, Yiping, Wu, Jianqiang, Lu, Meiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589299/
https://www.ncbi.nlm.nih.gov/pubmed/36299687
http://dx.doi.org/10.3389/fped.2022.992932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589299/
https://www.ncbi.nlm.nih.gov/pubmed/36299687
http://dx.doi.org/10.3389/fped.2022.992932

Ejemplares similares